ALTERNATE USE OF DEFERIPRONE AND DESFERRIOXAMINE IN PRIMARY SCHOOL CHILDREN WITH THALASSAEMIA MAJOR-Reference-Cited by-同舟云学术

ALTERNATE USE OF DEFERIPRONE AND DESFERRIOXAMINE IN PRIMARY SCHOOL CHILDREN WITH THALASSAEMIA MAJOR

Published:1999-07 Issue:1 Volume:106 Page:252-253
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:British Journal of Haematology

Author:

Aydinok ,Nisli ,Kavakli

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1365-2141.1999.01560.x/fullpdf

Reference5 articles.

1. Efficacy of desferrioxamine in preventing complications of iron overload in patients with thalassemia major;Brittenham;New England Journal of Medicine,1994

2. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis;Knodell;Hepatology,1991

3. Survival in medically treated patients with homozygous beta-thalassemia;Olivieri;New England Journal of Medicine,1994

4. Robbins , D.A. 1988 Methods for Biological Monitoring 223 227

5. Combined therapy with deferiprone and desferrioxamine;Wonke;British Journal Haematology,1998

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Single-center retrospective study of the effectiveness and toxicity of the oral iron chelating drugs deferiprone and deferasirox;PLOS ONE;2019-02-27

2. Thalassemia Syndromes;Hematology;2018

3. Increased survival and reversion of iron-induced cardiac disease in patients with thalassemia major receiving intensive combined chelation therapy as compared to desferoxamine alone;Blood Cells, Molecules, and Diseases;2010-08

4. Combined Therapy with Deferoxamine and Deferiprone;Annals of the New York Academy of Sciences;2005-11

5. Monitoring and treatment of iron overload: State of the art and new approaches;Seminars in Hematology;2005-04